Drug Manufacturers - General: 56 U.S.-Listed Stocks by Market Cap
EquiReason covers 56 U.S.-listed companies in the Drug Manufacturers - General industry (Healthcare sector), with a combined market cap of $3.87T. The largest by market cap: Eli Lilly and Company (LLY, $1.20T), Johnson & Johnson (JNJ, $635.1B), AbbVie Inc. (ABBV, $504.8B), Merck & Co., Inc. (MRK, $358.4B), AstraZeneca PLC (AZN, $274.1B).
Sector and industry classification and market cap at the latest close: EquiReason company data · financial statements on each company's page come from its SEC filings
Companies by market cap
| # | Company | Market cap |
|---|---|---|
| 1 | LLY Eli Lilly and Company | $1.20T |
| 2 | JNJ Johnson & Johnson | $635.1B |
| 3 | ABBV AbbVie Inc. | $504.8B |
| 4 | MRK Merck & Co., Inc. | $358.4B |
| 5 | AZN AstraZeneca PLC | $274.1B |
| 6 | AMGN Amgen Inc. | $237.5B |
| 7 | GILD Gilead Sciences, Inc. | $193.5B |
| 8 | PFE Pfizer Inc. | $171.2B |
| 9 | BMY Bristol-Myers Squibb Company | $125.6B |
| 10 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | $45.9B |
| 11 | ONC BeOne Medicines Ltd. | $42.9B |
| 12 | BIIB Biogen Inc. | $37.0B |
| 13 | BLTE BELITE BIO, INC | $5.8B |
| 14 | ABCL AbCellera Biologics Inc. | $3.6B |
| 15 | OGN Organon & Co. | $3.6B |
| 16 | ZLAB Zai Lab Ltd | $2.7B |
| 17 | HCM HUTCHMED (China) Ltd | $2.5B |
| 18 | BHC Bausch Health Companies Inc. | $2.4B |
| 19 | NAMS NewAmsterdam Pharma Co N.V. | $2.4B |
| 20 | BRVE Braveheart Bio, Inc. | $1.9B |
| 21 | GENB Generate Biomedicines, Inc. | $1.6B |
| 22 | QURE uniQure N.V. | $1.6B |
| 23 | CMPS COMPASS Pathways plc | $1.5B |
| 24 | GPCR Structure Therapeutics Inc. | $1.5B |
| 25 | MLTX MoonLake Immunotherapeutics | $1.0B |
| 26 | SLN Silence Therapeutics plc | $929.3M |
| 27 | NVCT Nuvectis Pharma, Inc. | $653.3M |
| 28 | GYRE GYRE THERAPEUTICS, INC. | $652.3M |
| 29 | AKTX Akari Therapeutics Plc | $640.6M |
| 30 | PBYI PUMA BIOTECHNOLOGY, INC. | $568.9M |
| 31 | STTK Shattuck Labs, Inc. | $551.0M |
| 32 | CBIO CRESCENT BIOPHARMA, INC. | $476.2M |
| 33 | DMAC DiaMedica Therapeutics Inc. | $470.2M |
| 34 | OVID Ovid Therapeutics Inc. | $421.8M |
| 35 | ASMB ASSEMBLY BIOSCIENCES, INC. | $404.0M |
| 36 | RZLT Rezolute, Inc. | $372.9M |
| 37 | NBP NovaBridge Biosciences | $365.5M |
| 38 | GALT GALECTIN THERAPEUTICS INC | $321.7M |
| 39 | CTNM Contineum Therapeutics, Inc. | $312.6M |
| 40 | TTRX Turn Therapeutics Inc. | $306.2M |
| 41 | BNTC Benitec Biopharma Inc. | $301.7M |
| 42 | PRLD Prelude Therapeutics Inc | $289.7M |
| 43 | IRD Opus Genetics, Inc. | $288.7M |
| 44 | QNRX Quoin Pharmaceuticals, Ltd. | $282.6M |
| 45 | AMRN AMARIN CORP PLC\UK | $261.2M |
| 46 | ABEO ABEONA THERAPEUTICS INC. | $251.6M |
| 47 | LYEL Lyell Immunopharma, Inc. | $230.1M |
| 48 | EVMN Evommune, Inc. | $185.1M |
| 49 | FHTX Foghorn Therapeutics Inc. | $118.8M |
| 50 | YARW Yarrow Bioscience, Inc. | $51.4M |
| 51 | IBO IMPACT BIOMEDICAL INC. | $30.8M |
| 52 | RMTI ROCKWELL MEDICAL, INC. | $28.0M |
| 53 | GTBP GT Biopharma, Inc. | $9.9M |
| 54 | CMMB Chemomab Therapeutics Ltd. | $7.5M |
| 55 | LGVN Longeveron Inc. | $5.1M |
| 56 | ENLV Enlivex Ltd. | $2.9M |
Questions
- What are the largest drug manufacturers - general stocks?
- By market cap: Eli Lilly and Company (LLY) $1.20T, Johnson & Johnson (JNJ) $635.1B, AbbVie Inc. (ABBV) $504.8B, Merck & Co., Inc. (MRK) $358.4B, AstraZeneca PLC (AZN) $274.1B, Amgen Inc. (AMGN) $237.5B, Gilead Sciences, Inc. (GILD) $193.5B, Pfizer Inc. (PFE) $171.2B, Bristol-Myers Squibb Company (BMY) $125.6B, TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) $45.9B.
- How many drug manufacturers - general companies are listed in the U.S.?
- EquiReason covers 56 U.S.-listed companies in this industry; the full list is above.
How these figures are read: methodology · EquiReason.